BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15908336)

  • 1. Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.
    Shah S; Gupta S; Shet T; Maheshwari A; Wuntkal R; Mohandas KM
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):306-7. PubMed ID: 15908336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell carcinoma of the liver: a case report.
    Kilinç N; Yalçin K; Değertekin H; Ozaydin M
    Turk J Gastroenterol; 2003 Sep; 14(3):211-4. PubMed ID: 14655070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell hepatocellular carcinoma treated with liver transplantation.
    Pecorella I; Ciardi A; Aiello E; Piras MR; Farci C; Di Tondo U
    Pathologica; 1994 Jun; 86(3):307-10. PubMed ID: 7808805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver.
    Gokden M; Shinde A
    Diagn Cytopathol; 2005 Sep; 33(3):166-72. PubMed ID: 16078249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoid carcinoma of the ovary and management.
    Lazaro J; Rubio D; Repolles M; Capote L
    Acta Obstet Gynecol Scand; 2007; 86(4):498-9. PubMed ID: 17486476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
    Chang YC; Dai YC; Chow NH
    Hepatogastroenterology; 2003; 50(53):1637-40. PubMed ID: 14571804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of basaloid anal carcinoma using cisplatin, 5-fluorouracil and resection of hepatic metastasis.
    Gurfinkel R; Walfisch S
    Tech Coloproctol; 2005 Dec; 9(3):235-6. PubMed ID: 16328122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
    Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
    Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous renal cell carcinoma and clear cell hepatocellular carcinoma mimicking metastatic disease.
    Hou TC; Wu CC; Yang CR; Wang J
    Pathol Res Pract; 2010 May; 206(5):342-5. PubMed ID: 19608351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma diagnosed by fine-needle aspiration of the parotid gland.
    Romanas MM; Cherian R; McGregor DH; Wu Y; May CL; Baranda JC
    Diagn Cytopathol; 2004 Jun; 30(6):401-5. PubMed ID: 15176027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
    Chen LT; Liu TW; Chao Y; Shiah HS; Chang JY; Juang SH; Chen SC; Chuang TR; Chin YH; Whang-Peng J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):217-26. PubMed ID: 16091059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
    Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
    Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of primary clear cell carcinoma of the liver].
    Ye XP; Li LQ; Peng T; Xiao KY; Su ZX; Shang LM; Su M; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):64-6. PubMed ID: 20211073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of soluble transferrin receptors study in hepatocellular carcinoma with underlying cirrhosis.
    Mehta R; Suvarna D; Mustafa CP; Sadasivan S
    Indian J Cancer; 2005; 42(4):215. PubMed ID: 16391443
    [No Abstract]   [Full Text] [Related]  

  • 18. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Kubota T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():625-8. PubMed ID: 16149595
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical presentation of hepatocellular carcinoma.
    UyBarreta V; Mikesh C; Simmons B; Beech DJ
    South Med J; 2000 May; 93(5):516-9. PubMed ID: 10832956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma.
    Murakata LA; Ishak KG; Nzeako UC
    Mod Pathol; 2000 Aug; 13(8):874-81. PubMed ID: 10955454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.